10x Genomics, Inc.

10X Genomics, Inc.

Health Information Services • Healthcare • Pleasanton, CA, United States • TXG (NMS)

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Wikipedia

Stock Performance (90 Days)

Data through Dec 24, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

A Look At 10x Genomics (TXG) Valuation After The New ImmuneScape Partnership Announcement - simplywall.st
simplywall.st • Jan 8
10x Genomics (TXG) Sees Target Price Increase in Latest Analyst Rating | TXG Stock News - GuruFocus
GuruFocus • Jan 7
10x Genomics (TXG) Stock Is Up, What You Need To Know - Yahoo Finance
Yahoo Finance • Jan 2
10x Genomics Stock (+10%): Analyst Upgrades Spark a Short Cover Rally - Trefis
Trefis • Jan 6
New research map aims to explain why some organ transplants fail - Stock Titan
Stock Titan • Jan 7

Other Health Information Services Companies

View All →
GE HealthCare Technologies Inc. logo GE Healthcare Technologies Inc.
$37.96B market cap
VEEVA SYSTEMS INC logo Veeva Systems Inc.
$36.68B market cap
Pro Medicus Ltd./ADR logo Pro Medicus Ltd.
$16.70B market cap
Tempus AI, Inc. logo Tempus AI, Inc.
$11.15B market cap
Doximity, Inc. logo Doximity, Inc.
$8.23B market cap
HEALTHEQUITY, INC. logo Healthequity, Inc.
$8.08B market cap

Frequently Asked Questions

Has 10x Genomics, Inc. had layoffs?
No layoff events have been recorded for 10x Genomics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does 10x Genomics, Inc. have?
10x Genomics, Inc. has approximately 1,306 employees.
What industry is 10x Genomics, Inc. in?
10x Genomics, Inc. operates in the Health Information Services industry, within the Healthcare sector.
Is 10x Genomics, Inc. a publicly traded company?
Yes, 10x Genomics, Inc. is publicly traded under the ticker symbol TXG on the NMS. The company has a market capitalization of approximately $2.08 billion.
Where is 10x Genomics, Inc. headquartered?
10x Genomics, Inc. is headquartered in Pleasanton, CA, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.